Intelligence Layer

News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Regulators

Regulatory Updates

FDA, EMA, PMDA, MHRA, and global regulatory coverage in one crawlable hub.

Trials

Clinical Trial Watch

Phase readouts, trial design updates, enrollment milestones, and study results.

Pipeline

Drug Pipeline

Regulatory pipeline signals, approvals, and market-moving development updates.

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

2x

daily refresh

Coverage

Latest indexed stories

9,373 stories indexed, page 136 of 157

🇺🇸Jan 1, 1970Industryeyenuk.com

Featured signal

Eyenuk Announces $6.2 Million Financing to Accelerate Adoption of FDA-cleared AI Technology for Detection of Diabetic Retinopathy

Publisher

Eyenuk

Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.

EyenukOriginal publisher link

Canonical metadata stays public, while full text remains on the original site.

🇺🇸Jan 1, 1970Industryeyenuk.com

Eyenuk Wins Juniper Research’s Digital Health Innovation Award for Best Digital Diagnostics Solution

EyenukOriginal source

🇺🇸Jan 1, 1970Industryeyenuk.com

Eyenuk Launches EyeArt AI System in South Africa in Collaboration with Discovery Health

EyenukOriginal source

🇺🇸Jan 1, 1970Industryeyenuk.com

Eyenuk Announces Publication of Strong EyeArt® Pivotal Clinical Trial Results in JAMA Network Open

EyenukOriginal source

🇺🇸Jan 1, 1970Industryeyenuk.com

Eyenuk Applauds CMS CY 2022 Medicare Physician Fee Schedule Final Rule to Establish National Price for Autonomous AI Technology

EyenukOriginal source

🇺🇸Jan 1, 1970Industryeyenuk.com

UK National Screening Committee Report Singles Out Eyenuk’s EyeArt as the Only Diabetic Eye Screening AI Technology Ready for Live Clinical Implementation in the National Health Service

EyenukOriginal source

🇺🇸Jan 1, 1970Industryeyenuk.com

Study Finds Eyenuk Artificial Intelligence Detects Diabetic Retinopathy with Far Greater Sensitivity than Ophthalmologists’ Dilated Exams

EyenukOriginal source

🇺🇸Jan 1, 1970Industryeyenuk.com

Eyenuk Announces FDA Clearance for EyeArt Autonomous AI System for Diabetic Retinopathy Screening

EyenukOriginal source

🇺🇸Jan 1, 1970Industryeyenuk.com

Vision Loss Rehabilitation Canada brings AI-driven diabetic eye screening to rural and Indigenous communities

EyenukOriginal source

🇺🇸Jan 1, 1970Industryeyenuk.com

Eyenuk Secures the First European Union MDR Certification for Autonomous AI Detection of Diabetic Retinopathy, Age-Related Macular Degeneration, and Glaucoma

EyenukOriginal source

🇩🇪Jan 1, 1970Industryevotec.com

Subscribe to Corporate News | Evotec

PharmAI (Evotec)Original source

🇪🇸Jan 1, 1970Industryesteve.com

Esteve | Media | News | ROSER GOMILA, JOINS ESTEVE AS CHIEF FINANCIAL OFFICER

Esteve (Pharma News)Original source

🇪🇸Jan 1, 1970Industryesteve.com

Esteve | Media | News | MAR HERNÁNDEZ JOINS ESTEVE AS CHIEF PEOPLE & ORGANIZATION OFFICER

Esteve (Pharma News)Original source

🇪🇸Jan 1, 1970Industryesteve.com

Esteve | Media | News | JACOB TOLSTRUP, JOINS ESTEVE AS CHIEF BUSINESS DEVELOPMENT OFFICER

Esteve (Pharma News)Original source

🇪🇸Jan 1, 1970Industryesteve.com

Esteve | Media | News | ESTEVE’S EXPANSION AND GROWTH IN EU AND USA ACCELERATES ITS TRANSFORMATION INTO A GLOBAL HEALTHCARE COMPANY

Esteve (Pharma News)Original source

🇪🇸Jan 1, 1970Industryesteve.com

Esteve | Media | News | ESTEVE WILL INVEST 100 MILLION EUROS IN THE CONSTRUCTION OF A NEW PLANT AT ITS INDUSTRIAL CENTRE IN CELRÀ (GIRONA)

Esteve (Pharma News)Original source

🇪🇸Jan 1, 1970Industryesteve.com

Esteve | Media | News | ESTEVE TO ACQUIRE TERSERA THERAPEUTICS’ INFUSION SPECIALTY THERAPIES BUSINESS UNIT, EXPANDING U.S. PRESENCE

Esteve (Pharma News)Original source

🇪🇸Jan 1, 1970Industryesteve.com

Esteve | Media | News | ESTEVE TO ACQUIRE MEDICINE TO TREAT MEDULLARY THYROID CANCER

Esteve (Pharma News)Original source

🇪🇸Jan 1, 1970Industryesteve.com

Esteve | Media | News | ESTEVE SIGNS A LICENSING AGREEMENT FOR A SEVERE PRIMARY INSULIN-LIKE GROWTH FACTOR 1 DEFICIENCY TREATMENT

Esteve (Pharma News)Original source

🇪🇸Jan 1, 1970Industryesteve.com

Esteve | Media | News | ESTEVE SIGNS A BINDING OFFER TO ACQUIRE HRA PHARMA RARE DISEASES, A PERRIGO COMPANY AFFILIATE

Esteve (Pharma News)Original source

🇪🇸Jan 1, 1970Industryesteve.com

Esteve | Media | News | ESTEVE REPORTS SIGNIFICANT GROWTH IN 2022 AND CONTINUES TO ADVANCE TOWARDS ITS VISION OF BECOMING AN INTERNATIONAL SPECIALTY PHARMA COMPANY

Esteve (Pharma News)Original source

🇪🇸Jan 1, 1970Industryesteve.com

Esteve | Media | News | ESTEVE RENEWS ITS BOARD OF DIRECTORS TO CONTINUE DRIVING STRATEGIC GROWTH

Esteve (Pharma News)Original source

🇪🇸Jan 1, 1970Industryesteve.com

Esteve | Media | News | ESTEVE INCREASES NET REVENUE BY 5% AND REAFFIRMS STRATEGY TOWARDS BECOMING A HIGHLY SPECIALIZED COMPANY

Esteve (Pharma News)Original source

🇪🇸Jan 1, 1970Industryesteve.com

Esteve | Media | News | ESTEVE CONSOLIDATES ITS DOUBLE-DIGIT GROWTH AND REACHES €710 MILLION IN NET REVENUE

Esteve (Pharma News)Original source

🇪🇸Jan 1, 1970Industryesteve.com

Esteve | Media | News | ESTEVE CDMO PLANS ADDITIONAL SPRAY DRYERS AND CONTAINMENT IN GIRONA, SPAIN, AND LAUNCHES NEW BRAND

Esteve (Pharma News)Original source

🇪🇸Jan 1, 1970Industryesteve.com

Esteve | Media | News | ESTEVE CDMO COMMENCES $15.5 MILLION EXPANSION OF CHICAGO SMALL MOLECULE API FACILITY

Esteve (Pharma News)Original source

🇪🇸Jan 1, 1970Industryesteve.com

Esteve | Media | News | ESTEVE BRINGS TO MARKET THE FIRST INHALED RESCUE TREATMENT DESIGNED TO CONTROL OFF EPISODES IN PARKINSON’S DISEASE¹

Esteve (Pharma News)Original source

🇪🇸Jan 1, 1970Industryesteve.com

Esteve | Media | News | ESTEVE BECOMES A B CORP COMPANY FOR ITS SOCIAL COMMITMENT, ENVIRONMENTAL AWARENESS, AND TRANSPARENCY

Esteve (Pharma News)Original source

🇪🇸Jan 1, 1970Industryesteve.com

Esteve | Media | News | ESTEVE AND MEDTRONIC ARE COLLABORATING TO ADDRESS CANCER PAIN PATIENTS’ NEEDS

Esteve (Pharma News)Original source

🇪🇸Jan 1, 1970Industryesteve.com

Esteve | Media | News | ESTEVE ACQUIRES REGIS TECHNOLOGIES, EXPANDING U.S. PRESENCE AND CAPABILITIES

Esteve (Pharma News)Original source

🇪🇸Jan 1, 1970Industryesteve.com

Esteve | Media | News | ESTEVE ACQUIRES HRA PHARMA RARE DISEASES

Esteve (Pharma News)Original source

🇺🇸Jan 1, 1970Researchemory.edu

Nondegree Programs | Emory University | Atlanta GA

Emory University School of MedicineOriginal source

🌍Jan 1, 1970Regulatoryema.europa.eu

Medicines for human use under evaluation | European Medicines Agency (EMA)

European Medicines Agency (EMA)Original source

🌍Jan 1, 1970Regulatoryema.europa.eu

Orphan designation: Overview | European Medicines Agency (EMA)

EMA Orphan MedicinesOriginal source

🌍Jan 1, 1970Regulatoryema.europa.eu

United for Health: EMA in WorldPride 2026

EMA Human MedicinesOriginal source

🌍Jan 1, 1970Regulatoryema.europa.eu

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 June 2026

EMA Human MedicinesOriginal source

🌍Jan 1, 1970Regulatoryema.europa.eu

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 16-18 June 2026

EMA Human MedicinesOriginal source

🌍Jan 1, 1970Regulatoryema.europa.eu

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2026

EMA Human MedicinesOriginal source

🌍Jan 1, 1970Regulatoryema.europa.eu

EU recommendations for 2026/2027 seasonal flu vaccine composition

EMA Human MedicinesOriginal source

🌍Jan 1, 1970Regulatoryema.europa.eu

ETF recommends updating COVID-19 vaccines to target XFG variant

EMA Human MedicinesOriginal source

🌍Jan 1, 1970Regulatoryema.europa.eu

EMA’s 2025 annual report shows strong approval numbers for human and veterinary medicines | European Medicines Agency (EMA)

EMA Human MedicinesOriginal source

🌍Jan 1, 1970Regulatoryema.europa.eu

EMA recommends revoking marketing authorisation for Tavneos | European Medicines Agency (EMA)

EMA Human MedicinesOriginal source

🌍Jan 1, 1970Regulatoryema.europa.eu

EMA Management Board: highlights of June 2026 meeting | European Medicines Agency (EMA)

EMA Human MedicinesOriginal source

🌍Jan 1, 1970Regulatoryema.europa.eu

EMA, AMA and African regulatory authorities join forces on Ebola outbreak response | European Medicines Agency (EMA)

EMA Human MedicinesOriginal source

🌍Jan 1, 1970Associationefpia.eu

USTR Launches Section 301 Investigation into Germany’s Pharmaceutical Pricing Policies

EFPIA (European Pharma Industry)Original source

🌍Jan 1, 1970Associationefpia.eu

Investing in health: vital for competitiveness, societal resilience and fiscal sustainability in Central and Eastern Europe

EFPIA (European Pharma Industry)Original source

🌍Jan 1, 1970Associationefpia.eu

Extending supplementary protection certificate (SPC) could increase European R&D investment tenfold

EFPIA (European Pharma Industry)Original source

🌍Jan 1, 1970Associationefpia.eu

Every €1 invested in new medicines returns €5.67 to Europe

EFPIA (European Pharma Industry)Original source

🌍Jan 1, 1970Associationefpia.eu

EFPIA welcomes EU Roadmap on phasing out animal testing for chemical safety assessments

EFPIA (European Pharma Industry)Original source

🌍Jan 1, 1970Associationefpia.eu

EFPIA response to the European Parliament vote on the EU-US trade agreement

EFPIA (European Pharma Industry)Original source

🌍Jan 1, 1970Associationefpia.eu

EFPIA response to the European Parliament Resolution on the UWWT Directive

EFPIA (European Pharma Industry)Original source

🌍Jan 1, 1970Associationefpia.eu

Why cardiovascular health checks: The case for EU action

EFPIA (European Pharma Industry)Original source

🌍Jan 1, 1970Associationefpia.eu

Safeguarding intellectual property and trade secrets in the European Health Data Space

EFPIA (European Pharma Industry)Original source

🌍Jan 1, 1970Associationefpia.eu

Impact of Innovative Medicines/Health Initatives projects on rare diseases

EFPIA (European Pharma Industry)Original source

🌍Jan 1, 1970Associationefpia.eu

EFPIA response to the General Court ruling on the Urban Wastewater Treatment Directive

EFPIA (European Pharma Industry)Original source

🌍Jan 1, 1970Associationefpia.eu

AI Across the Medicines Lifecycle: Insights from Preliminary Case Studies and Considerations for Policy

EFPIA (European Pharma Industry)Original source

🌍Jan 1, 1970Associationefpia.eu

Advancing Environmental Sustainability Assessment of Pharmaceuticals through Standardisation and Harmonisation of Product Carbon Footprint Assessment

EFPIA (European Pharma Industry)Original source

🌍Jan 1, 1970Associationefpia.eu

A comparative analysis of biopharmaceutical strategies in 10 countries

EFPIA (European Pharma Industry)Original source

🌍Jan 1, 1970Associationefpia.eu

Rare Diseases in a changing and competitive Europe

EFPIA (European Pharma Industry)Original source

🌍Jan 1, 1970Associationefpia.eu

Innovation in motion – Europe’s accelerating wave of new cancer medicines (Guest blog)

EFPIA (European Pharma Industry)Original source